The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
To provide the IRB approved mechanism for the prospective collection, analysis and reporting of data on patients who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed and for which peer reviewed, published data have demonstrated efficacy for this treatment approach.
Primary Outcome Measures
- Data followup [1 year]
Gather basic survival and complication data for operational and research databases for ongoing regulatory and futre operational queries
Planned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant
participation in any other treatment research protocol
Contacts and Locations
|1||Wake Forest Baptist Health||Winston-Salem||North Carolina||United States||27157|
Sponsors and Collaborators
- Wake Forest University Health Sciences
- Principal Investigator: Dianna Howard, MD, Wake Forest University Health Sciences
Study Documents (Full-Text)None provided.
- CCCWFU 95300